Insights

Stay up to date on PsychoGenics’ latest research, press releases, and industry developments in preclinical drug discovery. Combine our expertise with yours to spark the translational power of your next CNS breakthrough.

POSTER

Functional, Sensorimotor, and Cognitive Outcomes Following Unilateral MCAO in Rats

June 24, 2026
Read More
POSTER

Behavioral and pharmacological characterization of the isosorbide dinitrate model of headache in male and female rats

June 15, 2026
Read More
PUBLICATION

Behavior-Based Screening as an Approach to Polypharmacological Ligands, in Polypharmacology in Drug Discovery.

June 26, 2012
Read More
PUBLICATION

R6/2 Huntington’s disease Mice Develop Early and Progressive Abnormal Brain Metabolism and Seizures.

June 25, 2012
Read More
PUBLICATION

Caspase-6 Activity in a BAC HD Mouse Modulates Steady State Levels of Mutant Huntingtin Protein but is not Necessary for Production of a 586 Amino Acid Proteolytic Fragment.

June 24, 2012
Read More
PUBLICATION

Behavior-based screening as an approach to polypharmacological ligands.

November 29, 2011
Read More
PUBLICATION

HD Mouse Models reveal clear Deficits in Learning to Perform a Simple Instrumental Response. PLoS Currents: Huntington Disease.

November 14, 2011
Read More
PUBLICATION

Discovery of Isoxazole Analogs of Sazetidine-A as Selective alpha4 beta2-Nicotinic Acetylcholine Receptor (nAChR) Partial Agonists for the Treatment of Depression,

June 29, 2011
Read More
PUBLICATION

Comparative psychology and the grand challenge of drug discovery in psychiatry and neurodegeneration,

June 28, 2011
Read More
PUBLICATION

Effect of the rd1 mutation on motor performance in R6/2 and wild type mice [Internet]. Version 28.

March 15, 2011
Read More
PUBLICATION

Impulsive action and impulsive choice are mediated by distinct neuropharmacological substrates in rat

March 14, 2011
Read More